Video Education to Improve Blood Pressure Control in Patients With Ischemic Heart Disease and Hypertension (V-EDUCATE)

Keimyung University

Status: Completed

Conditions: Ischemic Heart Disease; Hypertension (HTN)

Treatments: Other: Control; Behavioral: Video Education

Study type: Interventional

Funder types: Other

Identifiers

NCT07210073

2024-02-053

Details and patient eligibility

About

We investigated whether video-based education using deepfake technology could improve blood pressure measurement adherence and medication adherence in patients with ischemic heart disease accompanied by hypertension.

Full description

Hypertension is a major risk factor for recurrent cardiovascular events in patients with ischemic heart disease, yet adherence to home blood pressure monitoring and prescribed medications remains suboptimal. Personalized and engaging educational strategies may help to improve adherence behaviors in this population.

This randomized controlled trial investigates the effectiveness of a video-based educational program, developed with deepfake technology, to deliver individualized health information. Participants are randomly assigned to either the intervention group, which receives the video education in addition to usual care, or the control group, which receives usual care alone.

The primary outcomes are adherence to home blood pressure monitoring and medication adherence after one month. Secondary outcomes include changes in office and home blood pressure, as well as 24-hour ambulatory blood pressure monitoring. The results of this study may provide evidence for scalable, technology-assisted strategies to enhance adherence and improve blood pressure control in high-risk cardiovascular patients.

Enrollment: 218 patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adults aged 19 years or older, both male and female, with a history of hypertension or who have taken antihypertensive medication at least once, satisfying one or more of the following ischemic heart disease conditions (PCI, CABG, CAD >50% by CCT or CAG), or patients with a history of hypertension or currently taking antihypertensive medication.
• Individuals who have voluntarily provided written consent to participate in this clinical trial.

Exclusion criteria

• SBP < 90 mmHg or DBP < 50 mmHg
• Individuals intolerant to all antihypertensive medications
• Patients with heart failure due to other causes, Pregnant women, those suspected of being pregnant, or those who are breastfeeding
• Patients whom the investigator deems legally or mentally unfit to participate in the clinical trial
• Patients who have participated in another clinical study involving investigational drugs within 4 weeks prior to screening.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

218 participants in 2 patient groups

Video education

Experimental group

Description:

Participants receive personalized video-based education developed using deepfake technology to replicate the patient's primary physician's voice, in addition to usual care.

Treatment:

Behavioral: Video Education

Standard Care

Active Comparator group

Description:

Participants receive standard treatment for ischemic heart disease and hypertension, without additional video-based education.

Treatment:

Other: Control